Literature DB >> 17502574

Indicators of poor prognosis of acute pericarditis.

Massimo Imazio1, Enrico Cecchi, Brunella Demichelis, Salvatore Ierna, Daniela Demarie, Aldo Ghisio, Franco Pomari, Luisella Coda, Riccardo Belli, Rita Trinchero.   

Abstract

BACKGROUND: The clinical search for indicators of poor prognosis of acute pericarditis may be useful for clinical triage of patients at high risk of specific causal conditions or complications. The aim of the present article is to assess the relationship between clinical features at presentation and specific causes or complications. METHODS AND
RESULTS: A total of 453 patients aged 17 to 90 years (mean age 52+/-18 years, 245 men) with acute pericarditis (post-myocardial infarction pericarditis was excluded) were prospectively evaluated from January 1996 to August 2004. A specific cause was found in 76 of 453 patients (16.8%): autoimmune in 33 patients (7.3%), neoplastic in 23 patients (5.1%), tuberculous in 17 patients (3.8%), and purulent in 3 patients (0.7%). In multivariable analysis, women (hazard ratio [HR] 1.67, 95% confidence interval [CI] 1.03 to 2.70; P=0.036) and patients with fever >38 degrees C (HR 3.56, 95% CI 1.82 to 6.95; P<0.001), subacute course (HR 3.97, 95% CI 1.66 to 9.50; P=0.002), large effusion or tamponade (HR 2.15, 95% CI 1.09 to 4.23; P=0.026), and failure of aspirin or of nonsteroidal anti-inflammatory drugs (HR 2.50, 95% CI 1.28 to 4.91; P=0.008) were at increased risk of specific causal conditions. After a mean follow-up of 31 months, complications were detected in 95 patients (21.0%): recurrences in 83 patients (18.3%), tamponade in 14 patients (3.1%), and constriction in 7 patients (1.5%). In multivariable analysis, women (HR 1.65, 95% CI 1.08 to 2.52; P=0.020) and patients with large effusion or tamponade (HR 2.51, 95% CI 1.37 to 4.61; P=0.003) and failure of aspirin or of nonsteroidal anti-inflammatory drugs (HR 5.50, 95% CI 3.56 to 8.51; P<0.001) were at increased risk of complications.
CONCLUSIONS: Specific clinical features (fever >38 degrees C, subacute course, large effusion or tamponade, and aspirin or NSAID failure) may be useful to identify higher risk of specific causal conditions and complications.

Entities:  

Mesh:

Year:  2007        PMID: 17502574     DOI: 10.1161/CIRCULATIONAHA.106.662114

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  67 in total

1.  Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study.

Authors:  Luca Cantarini; Orso Maria Lucherini; Antonio Brucato; Luca Barone; Davide Cumetti; Francesca Iacoponi; Donato Rigante; Giovanni Brambilla; Silvana Penco; Maria Giuseppina Brizi; Maria Cristina Patrosso; Guido Valesini; Bruno Frediani; Mauro Galeazzi; Rolando Cimaz; Giuseppe Paolazzi; Antonio Vitale; Massimo Imazio
Journal:  Clin Res Cardiol       Date:  2012-02-05       Impact factor: 5.460

2.  Management of constrictive pericarditis in the 21st century.

Authors:  Geoffrey C Clare; Richard W Troughton
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-12

3.  A case series and systematic literature review of anakinra and immunosuppression in idiopathic recurrent pericarditis.

Authors:  Ian C Scott; Vijay Hajela; Philip N Hawkins; Helen J Lachmann
Journal:  J Cardiol Cases       Date:  2011-08-12

Review 4.  Recurrent Pericarditis: Modern Approach in 2016.

Authors:  Massimo Imazio; Yehuda Adler; Philippe Charron
Journal:  Curr Cardiol Rep       Date:  2016-06       Impact factor: 2.931

5.  Pericarditis as a Marker of Occult Cancer and a Prognostic Factor for Cancer Mortality.

Authors:  Kirstine Kobberøe Søgaard; Dóra Körmendiné Farkas; Vera Ehrenstein; Krishnan Bhaskaran; Hans Erik Bøtker; Henrik Toft Sørensen
Journal:  Circulation       Date:  2017-06-29       Impact factor: 29.690

Review 6.  Recurrent pericarditis: still idiopathic? The pros and cons of a well-honoured term.

Authors:  Antonio Brucato; Massimo Imazio; Paul C Cremer; Yehuda Adler; Bernhard Maisch; George Lazaros; Marco Gattorno; Alida L P Caforio; Renzo Marcolongo; Giacomo Emmi; Alberto Martini; Allan L Klein
Journal:  Intern Emerg Med       Date:  2018-07-18       Impact factor: 3.397

Review 7.  Effusive-constrictive pericarditis.

Authors:  Faisal F Syed; Mpiko Ntsekhe; Bongani M Mayosi; Jae K Oh
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

8.  Primary Streptococcus pneumoniae pericarditis.

Authors:  Matthew N Peters; Kathleen S Hesterman; Morgan J Katz; Meredith B Barnes; Ryan R Brown; Vikram S Nijjar; Mohannad B Bisharat; Anand M Irimpen
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-01

9.  Subacute effusive-constrictive pericarditis: Echocardiography-guided diagnosis and management.

Authors:  Naoto Ohsawa; Yoko Nakaoka; Sho-Ichi Kubokawa; Toru Kubo; Naohito Yamasaki; Hiroaki Kitaoka; Kazuya Kawai; Naohisa Hamashige; Yoshinori Doi
Journal:  J Cardiol Cases       Date:  2017-04-26

Review 10.  Clinical Utility of [18F]FDG-PET /CT in Pericardial Disease.

Authors:  Min-Sun Kim; Eun-Kyung Kim; Joon Young Choi; Jae K Oh; Sung-A Chang
Journal:  Curr Cardiol Rep       Date:  2019-08-02       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.